LEADER 03360nam  22006375  450 
001 9910484023103321
005 20251117001456.0
010   $a3-030-74173-7
024 7 $a10.1007/978-3-030-74173-0
035   $a(CKB)4100000011954638
035   $a(DE-He213)978-3-030-74173-0
035   $a(MiAaPQ)EBC6639211
035   $a(Au-PeEL)EBL6639211
035   $a(OCoLC)1256542201
035   $a(PPN)269152342
035   $a(EXLCZ)994100000011954638
100   $a20210608d2021      u|         0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aFluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria $eSide-effects of Fluoroquinolones /$fby Stefan Pieper
205   $a1st ed. 2021.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2021.
215   $a1 online resource (X, 70 p. 2 illus.)
311 08$a3-030-74172-9 
320   $aIncludes bibliographical references and index.
327   $a1 Introduction to Fluoroquinolone-Associated Disability (FQAD) -- 2 FQAD and Oxidative Stress and Mitochondrial Toxicity -- 3 FQAD and Musculoskeletal Damage / Collagen Disorder -- 4 FQAD and Neurotoxicity / Peripheral Neuropathy (PN) / Autonomic Neuropathy / Small Fibre Neuropathy -- 5 FQAD and Neuropsychiatric Adverse Effects -- 6 Diagnostic criteria of the FQAD -- 7 Inside Story - Practical experience with FQAD Patients.
330   $aIn this book, Stefan Pieper supports doctors and therapists in easily diagnosing FQAD and in better and more adequately dealing with FQAD patients. Fluoroquinolones, as one of the most common and effective groups of antibiotics, are known to have a distinct spectrum of side effects. These adverse effects are rare in percentage terms, but frequent in absolute numbers due to the enormous quantities of prescriptions. Because they are usually quite severe and wide-ranging, they tend to run like a syndrome and have been classified by the FDA as a separate condition, the FQAD, because of their frequency, severity and risk of disability. This book presents for the first time a comprehensive description and classification of the clinical picture and a proposal for a clinical diagnostic tool based on diagnostic criteria.
606   $aInternal medicine
606   $aFamily medicine
606   $aCritical care medicine
606   $aInternal Medicine
606   $aGeneral Practice and Family Medicine
606   $aIntensive Care Medicine
606   $aAntibiòtics$2thub
606   $aEfectes secundaris dels medicaments$2thub
608   $aLlibres electrònics$2thub
615  0$aInternal medicine.
615  0$aFamily medicine.
615  0$aCritical care medicine.
615 14$aInternal Medicine.
615 24$aGeneral Practice and Family Medicine.
615 24$aIntensive Care Medicine.
615  7$aAntibiòtics.
615  7$aEfectes secundaris dels medicaments
676   $a615.7922
700   $aPieper$b Stefan$0888507
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910484023103321
996   $aFluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria$91985016
997   $aUNINA